XORTX Outlines Anticipated Health Canada Clinical Trial Application for XRx-026 for Gout
● Clinical Trial Application planned for filing with Health Canada, extending the Company’s international regulatory strategy for gout program XRx-026 ● CALGARY, Alberta, Oct.
08, 2026 (GLOBE NEWSWIRE) — XORTX Therapeuti
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.